Process of manufacture of annexin v
US-2024116982-A1 · Apr 11, 2024 · US
US8945895B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8945895-B2 |
| Application number | US-84795610-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 30, 2010 |
| Priority date | Jul 31, 2009 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods.
Opening claim text (preview).
The invention claimed is: 1. A method for purifying recombinant a disintegrin-like and metallopeptidase with thrombospondin type I motif 13 (ADAMTS13) protein from a sample comprising ADAMTS13 protein and non-ADAMTS13 impurities, the method comprising the steps of: (a) chromatographically contacting the sample with hydroxyapatite under conditions that allow said ADAMTS13 protein to appear in a flow through fraction from said hydroxyapatite by said ADAMTS13 protein not binding to s…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.